159 related articles for article (PubMed ID: 15163657)
1. A long-term latent reservoir for HIV-1: discovery and clinical implications.
Siliciano JD; Siliciano RF
J Antimicrob Chemother; 2004 Jul; 54(1):6-9. PubMed ID: 15163657
[TBL] [Abstract][Full Text] [Related]
2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
3. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
[TBL] [Abstract][Full Text] [Related]
4. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF
Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
[TBL] [Abstract][Full Text] [Related]
7. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF
Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
[TBL] [Abstract][Full Text] [Related]
8. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
9. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
[TBL] [Abstract][Full Text] [Related]
10. Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.
Kulkosky J; Pomerantz RJ
Clin Infect Dis; 2002 Dec; 35(12):1520-6. PubMed ID: 12471572
[TBL] [Abstract][Full Text] [Related]
11. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
[TBL] [Abstract][Full Text] [Related]
12. The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution.
Lambotte O; Chaix ML; Gubler B; Nasreddine N; Wallon C; Goujard C; Rouzioux C; Taoufik Y; Delfraissy JF
AIDS; 2004 May; 18(8):1147-58. PubMed ID: 15166530
[TBL] [Abstract][Full Text] [Related]
13. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
14. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
15. Eliminating HIV-1 reservoirs.
Pomerantz RJ
Curr Opin Investig Drugs; 2002 Aug; 3(8):1133-7. PubMed ID: 12211403
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
Siliciano JD; Kajdas J; Finzi D; Quinn TC; Chadwick K; Margolick JB; Kovacs C; Gange SJ; Siliciano RF
Nat Med; 2003 Jun; 9(6):727-8. PubMed ID: 12754504
[TBL] [Abstract][Full Text] [Related]
17. Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.
Tran TA; de Goër de Herve MG; Hendel-Chavez H; Dembele B; Le Névot E; Abbed K; Pallier C; Goujard C; Gasnault J; Delfraissy JF; Balazuc AM; Taoufik Y
PLoS One; 2008 Oct; 3(10):e3305. PubMed ID: 18827929
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
Sankatsing SU; van Praag RM; van Rij RP; Rientsma R; Jurriaans S; Lange JM; Prins JM; Schuitemaker H
Antivir Ther; 2003 Apr; 8(2):137-42. PubMed ID: 12741626
[TBL] [Abstract][Full Text] [Related]
19. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials.
Haggerty CM; Pitt E; Siliciano RF
Curr Opin HIV AIDS; 2006 Jan; 1(1):62-8. PubMed ID: 19372786
[TBL] [Abstract][Full Text] [Related]
20. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]